PMH31 12 MONTH COST-UTILITY ANALYSIS OF ORAL ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67777-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)67777-7/fulltext
Title :
PMH31 12 MONTH COST-UTILITY ANALYSIS OF ORAL ANTIPSYCHOTIC TREATMENTS IN PATIENTS WITH SCHIZOPHRENIA IN THE PAN-EUROPEAN SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67777-7&doi=10.1016/S1098-3015(10)67777-7
First page :
Section Title :
Open access? :
No
Section Order :
375